Camlin Fine Sciences Limited
Camlin Fine Sciences Limited operates in Specialty Chemicals, part of the Commodities sector. It booked ₹520 cr of revenue in its latest quarter (Q1 FY27) and kept -6.1% of sales as profit.
From the company's consolidated segment filings (Ind AS 108). Margin is segment operating profit (before interest & tax) over segment revenue; reconciliation rows like inter-segment eliminations are excluded from the mix.
Healthier than 34% of companies in Commodities, on all six measures of filed financials. Each measure is ranked against the 25–173 companies that reported it.
Measures financial condition, not whether to buy. Learn what this score means · How this is calculated
- RSI (14)
- 36
At close. Not part of the score.
How much profit it earns on the money it employs
How much it owes, and whether earnings cover the interest
Whether reported profit actually arrives as cash
Whether sales and profit have grown, and how steadily
What today's price implies, against our models or its peers
How much of the promoters' stake is pledged, and how much they hold
What if I invest in CAMLINFINE?
Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.
The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.
P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.
An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.
| Revenue from Operations | ₹520 cr |
| Other Income | ₹1 cr |
| Total Income | ₹521 cr |
| Cost of Materials | ₹312 cr |
| Purchases of Stock-in-Trade | ₹6 cr |
| Inventory Change (±) | ₹-12 cr |
| Employee Benefit Expense | ₹73 cr |
| Finance Costs | ₹14 cr |
| Depreciation & Amortisation | ₹19 cr |
| Other Expenses | ₹131 cr |
| Total Expenses | ₹544 cr |
| Exceptional Items | ₹-11 cr |
| Profit before Tax | ₹-34 cr |
| Tax Expense | ₹-46.3 L |
| Share of JV / Associates | ₹1 cr |
| Net Profit | ₹-34 cr |
| Net margin on total income | -6.5% |
The company made a net loss of ₹34 cr this quarter — income covered only ₹96 of every ₹100 it spent on costs and tax.
| Metric | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|
| Revenue | 457 cr | 425 cr | 520 cr |
| Total income | 460 cr | 449 cr | 521 cr |
| Expenses | 470 cr | 447 cr | 544 cr |
| Profit before tax | -28 cr | -7 cr | -34 cr |
| Tax | 4.5 L | -6 cr | -46.3 L |
| Net profit (owners' share) | -36 cr | 88 cr | -32 cr |
| Net margin (owners' share, on revenue) | -7.9% | 20.8% | -6.1% |
| EPS (₹) | -1.44 | 0.35 | -1.60 |
| Company | Price | Market cap | P/E | ROE | Net margin | 1-yr return |
|---|---|---|---|---|---|---|
| Pidilite Industries Limited | ₹1,552 | ₹1.58 L cr | 45.3 | 32.2% | 19.2% | — |
| Gujarat Fluorochemicals Limited | ₹4,472 | ₹49,190 cr | 55.4 | 11.2% | 13.9% | — |
| Navin Fluorine International Limited | ₹8,220 | ₹42,169 cr | 43.3 | 24.5% | 23.3% | — |
| Deepak Nitrite Limited | ₹1,605 | ₹21,889 cr | 15.9 | 23.6% | 13.4% | — |
| Aether Industries Limited | ₹1,623 | ₹21,543 cr | 85.1 | 10.2% | 19.2% | — |
| Atul Limited | ₹6,134 | ₹18,057 cr | 18.4 | 15.8% | 13.3% | — |
| Aarti Industries Limited | ₹477 | ₹17,287 cr | 27.9 | 10.4% | 6.5% | — |
| Fine Organic Industries Limited | ₹5,202 | ₹15,949 cr | 28.9 | 20.7% | 19.9% | — |
| BASF India Limited | ₹3,602 | ₹15,591 cr | 11.2 | 36.4% | 7.5% | — |
| Action | Detail | Ex-date |
|---|---|---|
| Rights issue | 41:5 | 8 Jan 2025 |
| Dividend | ₹0.45 / share | 28 Jul 2016 |
| Dividend | ₹0.45 / share | 27 Jul 2015 |
| Stock split | Stock Split From Rs.2/- to Rs.1/- | 4 Sep 2014 |
| Dividend | ₹0.7 / share | 24 Jul 2014 |
| Dividend | ₹0.6 / share | 1 Aug 2013 |
A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.
Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.
When a company raises money from investors, it has to say up front what the money is for. The rules then make it report, every three months until the money is gone, how much of each of those things it has actually paid for — so a promise made while asking for the money can be checked afterwards.
As of Mar 2026, the company says it has spent 99% of what it set aside, leaving ₹1 cr still to be spent. India Ratings & Research Private Limited watches the spending on the exchange’s behalf.
Every figure above is taken from the statement the company files with the stock exchange each quarter, for as long as money it has raised remains unspent. The only thing we work out is how much of each stated purpose has been paid for — one number divided by another from the same filing. Whether a plan that changed was a good change is not something a filing can tell you. See the filing